1

CASES

— GUCOVSCHI ROZENSHTEYN, PLLC

Final Approval Granted for $3.8 Million CVS Lidocaine Class Action Settlement

A class action lawsuit against CVS Pharmacy has reached a major milestone with the final approval of a $3.8 million settlement. The lawsuit, spearheaded by GR Firm and Bursor & Fisher P.A., challenged CVS’ marketing of its lidocaine products. Plaintiffs accused CVS of falsely advertising these products as “maximum strength,” leading to misleading claims that resulted in this legal battle.

The Claims and Allegations

Consumers filed the class action lawsuit claiming that CVS misrepresented its lidocaine patches, creams, roll-ons, and sprays as offering the “maximum strength” of lidocaine available. Plaintiffs argued that this marketing was misleading, as the products did not deliver the strongest possible concentration of lidocaine, as advertised.

In addition to the “maximum strength” claim, the lawsuit also targeted CVS’ advertisements that claimed its lidocaine patches could remain adhered to the skin for 8 to 12 hours. According to the lawsuit, these representations were untrue, further deceiving consumers.

Settlement Details

Under the terms of the settlement, CVS has agreed to pay $3.8 million to consumers who purchased the affected products. Consumers who purchased any of the eligible CVS-branded lidocaine patches, creams, roll-ons, or sprays can file a claim, and no proof of purchase is required. This opens the door for many to receive compensation without the burden of providing receipts or additional documentation.

More at the link: https://topclassactions.com/lawsuit-settlements/closed-settlements/cvs-lidocaine-false-advertising-3-8m-class-action-settlement/

Previous News Calendar

DAZN-streaming-apps-deposit
The 32-page DAZN lawsuit accuses the streamer of unilaterally charging customers yearly or monthly renewal...
Read More
11
September
2024
peacock
GR Firm and Bursor & Fisher P.A. have successfully reached a proposed settlement in a class action...
Read More
09
September
2024
cvs
A class action lawsuit against CVS Pharmacy has reached a major milestone with the final approval of...
Read More
26
August
2024
adobe image
The complaint, filed by Gucovschi Rozenshteyn and Bursor & Fisher in the U.S. District Court...
Read More
01
July
2024
240603-Poppi-Lawsuit-a-prebiotic-soda-ac-957p-8a52eb
On May 29, 2024, GR Firm filed a lawsuit in U.S. District Court in San Francisco on behalf of Kristin...
Read More
29
May
2024
Justice-Scale-Blind
On September 6, 2023, GR Firm took a significant legal stride by launching a class action lawsuit against...
Read More
05
September
2023
images
GR Firm, in collaboration with co-counsel from Bursor & Fisher, filed a class action lawsuit against...
Read More
25
August
2023
istockphoto-137133407-170667a
On August 22, 2023, GR Firm launched a groundbreaking and critically important legal action, titled Nasser...
Read More
22
August
2023
view-building-architecture-london-city
In May 2023, GR Firm took a decisive step in the pursuit of consumer justice by initiating a class action...
Read More
19
May
2023
cubic-mock-up-billboard-city-scape
GR Firm is proud to announce that we prevailed on a class action motion to dismiss (MTD) against Walgreens,...
Read More
28
March
2023
CONTACT US

212 884 4230

info@gr-firm.com

FOLLOW US
SUBMIT CASE IDEA

COPYRIGHT © 2024 GR Firm. All Rights Reserved.

Scroll to Top